SCHEMBL5307271

SCHEMBL5307271

[c]1[nH]ccc1-c1cccnn1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.32
GOT1 P17174 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4986721 0.74 KDM4E (0.50)
SCHEMBL1456807 0.71 GOT1 (0.46) NPY5RGOT1
SCHEMBL30792004 0.71 GOT1 (0.46) NPY5RGOT1
SCHEMBL29442588 0.71 GOT1 (0.46) NPY5RGOT1
SCHEMBL1925074 0.68 GOT1 (0.33) NPY5RGOT1
SCHEMBL579172 0.68 TP53 (0.32) NPY5RGOT1
SCHEMBL584299 0.67 HDAC4 (0.35) GOT1
SCHEMBL317129 0.67 GOT1 (0.32) GOT1
SCHEMBL13911004 0.67 GOT1 (0.42) NPY5RGOT1
SCHEMBL8135893 0.65 KMT2A (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784224-A2 EGFR KINASE INHIBITOR COMBINATIONS FOR TREATING RESPIRATORY AND GASTROINTESTINAL DISORDERS Boehringer Ingelheim International GmbH (DE) 2007-05-16 EP claimed
WO-2006015775-A2 EGFR KINASE INHIBITOR COMBINATIONS FOR TREATING RESPIRATORY AND GASTROINTESTINAL DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-02-16 WO claimed
US-6080763-A INHIBIT THE RELEASE OF INFLAMMATORY CYTOKINES, E.G., TUMOR NECROSIS FACTOR AND INTERLEUKIN-1; USEFUL TO TREAT CHRONIC INFLAMMATORY DISEASE; AUTOIMMUNE DISEASES, E.G. RHEUMATOID ARTHRITIS, OSTEOPOROSIS; PYRAZOLYLUREAS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2000-06-27 US claimed
CN-113993861-B Phenyl ethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, compositions and methods thereof 凌科药业(杭州)有限公司 2024-05-14 CN disclosed
CN-117956990-A Compositions and methods for treating lipomatous pain 拉结尔治疗有限公司 2024-04-30 CN disclosed
CN-117751106-A Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2H-pyranylacetic acid compounds as LPA antagonists 唯久生物技术(苏州)有限公司 2024-03-22 CN disclosed
EP-3083639-B1 CYCLIC SULFONE AND SULFOXIMINE ANALOGS AND USES THEREOF PELOTON THERAPEUTICS INC (US) 2019-05-29 EP disclosed